TY  - GEN
AU  - Stevenson,Matt D
AU  - Macdonald,Frances C
AU  - Langley,Jonathan
AU  - Hunsche,Elke
AU  - Akehurst,Ron
TI  - The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III
SN  - 1524-4733
PY  - 2010///0917
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antihypertensive Agents
KW  - economics
KW  - Bosentan
KW  - Child
KW  - Confidence Intervals
KW  - Connective Tissue Diseases
KW  - complications
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Epoprostenol
KW  - Female
KW  - Health Care Costs
KW  - Health Expenditures
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Models, Economic
KW  - Palliative Care
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
KW  - Sulfonamides
KW  - United Kingdom
KW  - World Health Organization
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1524-4733.2009.00568.x
ER  -